$14.78
-0.51[-3.34%]
At close: Jun 6
$14.78
0[0.00%]
After Hours: 4:45PM EDT
Bilibili
(NASDAQ:BILI)Bilibili Stock (NASDAQ:BILI), Analyst Ratings, Price Targets, Predictions
Bilibili Inc has a consensus price target of $32.94, established from looking at the 56 latest analyst ratings. The last 3 analyst ratings were released from UBS, Benchmark, and Barclays on May 31, 2024, May 24, 2024, and May 24, 2024. With an average price target of $16 between UBS, Benchmark, and Barclays, there's an implied 8.25% upside for Bilibili Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
UBS
Benchmark
Barclays
CLSA
Mizuho
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Bilibili
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/31/2024 | Buy Now | 21.79% | UBS | Felix Liu | $11.9 → $18 | Upgrade | Neutral → Buy | Get Alert |
| 05/24/2024 | Buy Now | 8.25% | Benchmark | Fawne Jiang | $15 → $16 | Maintains | Buy | Get Alert |
| 05/24/2024 | Buy Now | -5.28% | Barclays | Jiong Shao | $10 → $14 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 05/10/2024 | Buy Now | 13.67% | CLSA | Elinor Leung | $12.2 → $16.8 | Upgrade | Outperform → Buy | Get Alert |
| 05/10/2024 | Buy Now | 15.02% | Mizuho | James Lee | $15 → $17 | Maintains | Buy | Get Alert |
| 03/11/2024 | Buy Now | -15.43% | Citigroup | Brian Gong | $18 → $12.5 | Downgrade | Buy → Neutral | Get Alert |
| 03/11/2024 | Buy Now | -25.58% | JP Morgan | Daniel Chen | $10 → $11 | Upgrade | Underweight → Neutral | Get Alert |
| 03/08/2024 | Buy Now | 1.49% | Benchmark | Fawne Jiang | $21 → $15 | Maintains | Buy | Get Alert |
| 03/08/2024 | Buy Now | 1.49% | Mizuho | James Lee | $16 → $15 | Maintains | Buy | Get Alert |
| 01/17/2024 | Buy Now | 8.25% | Mizuho | James Lee | $18 → $16 | Maintains | Buy | Get Alert |
| 12/04/2023 | Buy Now | -10.69% | UBS | Felix Liu | $22 → $13.2 | Downgrade | Buy → Neutral | Get Alert |
| 11/30/2023 | Buy Now | 42.08% | Benchmark | Fawne Jiang | $35 → $21 | Maintains | Buy | Get Alert |
| 11/30/2023 | Buy Now | 5.55% | Goldman Sachs | Lincoln Kong | $17.4 → $15.6 | Maintains | Neutral | Get Alert |
| 11/30/2023 | Buy Now | -32.34% | Barclays | Jiong Shao | $15 → $10 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 10/12/2023 | Buy Now | 17.73% | Goldman Sachs | Lincoln Kong | $19.6 → $17.4 | Maintains | Neutral | Get Alert |
| 08/21/2023 | Buy Now | 1.49% | Barclays | Jiong Shao | $16 → $15 | Maintains | Equal-Weight | Get Alert |
| 08/18/2023 | Buy Now | 48.85% | UBS | Felix Liu | $23 → $22 | Maintains | Buy | Get Alert |
| 08/18/2023 | Buy Now | 136.81% | Benchmark | Jason English | → $35 | Reiterates | Buy → Buy | Get Alert |
| 08/18/2023 | Buy Now | 711.91% | Baird | David Koning | $140 → $120 | Maintains | Neutral | Get Alert |
| 07/27/2023 | Buy Now | -12.04% | JP Morgan | Daniel Chen | → $13 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 07/25/2023 | Buy Now | 8.25% | HSBC | Charlotte Wei | $17 → $16 | Maintains | Hold | Get Alert |
| 06/08/2023 | Buy Now | 55.62% | UBS | Felix Liu | $35 → $23 | Maintains | Buy | Get Alert |
| 06/05/2023 | Buy Now | 136.81% | Benchmark | Jason English | → $35 | Reiterates | Buy → Buy | Get Alert |
| 06/02/2023 | Buy Now | 136.81% | Benchmark | Jason English | → $35 | Reiterates | Buy → Buy | Get Alert |
| 06/02/2023 | Buy Now | 69.15% | B of A Securities | Brad Sills | $28 → $25 | Maintains | Buy | Get Alert |
| 06/02/2023 | Buy Now | 62.38% | Citigroup | Brian Gong | $28 → $24 | Maintains | Buy | Get Alert |
| 06/02/2023 | Buy Now | 15.02% | HSBC | Charlotte Wei | $22 → $17 | Maintains | Hold | Get Alert |
| 03/03/2023 | Buy Now | 136.81% | Benchmark | Jason English | → $35 | Reiterates | → Buy | Get Alert |
| 03/03/2023 | Buy Now | 89.45% | Citigroup | Brian Gong | → $28 | Upgrade | Neutral → Buy | Get Alert |
| 01/09/2023 | Buy Now | 71.18% | Goldman Sachs | Lincoln Kong | $22.2 → $25.3 | Maintains | Neutral | Get Alert |
FAQ
What is the target price for Bilibili (BILI)?
The latest price target for Bilibili (NASDAQ: BILI) was reported by UBS on May 31, 2024. The analyst firm set a price target for $18.00 expecting BILI to rise to within 12 months (a possible 21.79% upside). 22 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Bilibili (BILI)?
The latest analyst rating for Bilibili (NASDAQ: BILI) was provided by UBS, and Bilibili upgraded their buy rating.
When was the last upgrade for Bilibili (BILI)?
The last upgrade for Bilibili Inc happened on May 31, 2024 when UBS raised their price target to $18. UBS previously had a neutral for Bilibili Inc.
When was the last downgrade for Bilibili (BILI)?
The last downgrade for Bilibili Inc happened on March 11, 2024 when Citigroup changed their price target from $18 to $12.5 for Bilibili Inc.
When is the next analyst rating going to be posted or updated for Bilibili (BILI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bilibili, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bilibili was filed on May 31, 2024 so you should expect the next rating to be made available sometime around May 31, 2025.
Is the Analyst Rating Bilibili (BILI) correct?
While ratings are subjective and will change, the latest Bilibili (BILI) rating was a upgraded with a price target of $11.90 to $18.00. The current price Bilibili (BILI) is trading at is $14.78, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.